Funding Rounds
ITM

ITM Series D (2024, $205M)

ITM

Developer of radiomolecular precision therapeutics and diagnostics for treatment of tumors.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series D

Raised Amount: $205.00M

Raised Date: 2024-06-01

Investors